Pace Life Sciences LLC, a central laboratory and contract development and manufacturing organization, received an “overall positive review” from the Food & Drug Administration (FDA) after a comprehensive three-day inspection of its San Germán laboratory’s quality systems and data delivery processes. Read more here.
Long-standing reputation for robust quality is confirmed as company enters 2024 SAN GERMAN, PR., March 28, 2024 (NEWSWIRE.COM): Pace® Life Sciences, LLC, a full-service FDA-registered central laboratory and contract development and manufacturing organization (CDMO) announced the receipt of an overall positive review from The Food & Drug Administration (FDA), following a three-day general inspection of …
Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network Minneapolis, MN [March 14, 2024] Pace® Life Sciences, LLC, a contract development, and manufacturing organization (CDMO), announced today that it has acquired the Lebanon, New Jersey laboratory facility (formerly Whitehouse Analytical Laboratories) from Curia, a global contract research, development, and manufacturing (CDMO) company. …
Pace® Life Sciences Acquires New Jersey Laboratory from Curia Read More »
Von Rohr brings over 25 years of experience to company Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, announced today that Dawn Von Rohr has been named Division President. Von Rohr will be responsible for driving growth and continued innovations within the Pace® …
Pace® Life Sciences Appoints Dawn Von Rohr as Division President Read More »
By John Gerken, Vice President of Corporate Accounts and Specialty Analytical Services, Pace (P&GJ) — Emergency situations, like explosions due to pipeline ruptures, often happen instantly and without warning. Pipeline managers know about the risks that come with the job, but the aftereffects of pipeline ruptures and leaks are often secondary to protecting human life. …
Crucial Role of Testing Labs in Pipeline Emergency Response Read More »
Pace® Life Sciences continues to make investments to broaden their comprehensive suite of oral solid dose development offerings. ANN ARBOR, Mich., December 19, 2023 (Newswire) – Pace® Life Sciences, a full-service contract development and manufacturing organization (CDMO) and a Division of Pace®, a Science and Technology Company, adds liquid capsule filling technology to their comprehensive suite of …
Pace® Life Sciences Adds Liquid Capsule Filling Technology Read More »
DelNova’s partnership will enable clinical development of its lead candidate ReViVox® for the rescue of undesirable outcomes which may arise from a botulinum neurotoxin (BoNT) treatment such as Botox®. Pace® Life Sciences provides a full suite of contract CMC development, clinical trials materials manufacturing, and regulatory compliance, services to the biopharmaceutical industries. SAN DIEGO, Oct. …
Delnova Unveils Partnership With Pace® Life Sciences To Boost Capabilities Read More »
Greg Kupp – President Life Sciences Division & Frank Tagliaferri – VP of Technical DevelopmentPace® Life Sciences were recently interviewed by Investment Reports. Read the full inter view here.
Pace ® is happy to share news from our client, ReveraGen BioPharma Inc., on a significant accomplishment! ReveraGen Completes NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy. Pace® Ann Arbor (legacy Velesco Pharmaceutical Services) contributed significantly to this success. Velesco Pharma (now Pace®) performed the drug product clinical formulation development and all drug …
ReveraGen Completes NDA Submission to FDA for Vamorolone in Duchenne Muscular Dystrophy Read More »